摘要
线粒体功能障碍明显地促成了阿兹海默氏症(AD)的病理进程。在这里,我们研究了AD与血小板线粒体呼吸频率、呼吸链复合物活性和辅酶Q10血浆浓度的变化之间的关系。从AD患者获取完整的血小板,我们观察到内源性基础呼吸频率降低,电子传递系统(ETS)的最大容量减少,抑制ETS的复和物I后呼吸频率增高。当柠檬酸合酶活性正常时,鱼藤酮抑制了呼吸频率,复合物I活性显著改变。透化的血小板里的复合物I基质的增加完全恢复了线粒体的呼吸功能。线粒体呼吸参数的变化与AD的进展不相关,除了透化的血小板里的ETS的容量。AD患者里复合物I的活性增加,复合物IV活性降低,辅酶Q10的血浆浓度减少。我们的数据表明,进入到氧化磷酸化系统的两种基质都不足,ETS复合物的功能障碍是从AD患者完整的血小板里观察到的呼吸减少的原因。复合物IV活性、完整的血小板的呼吸频率、透化的血小板的ETS的容量的分析可能描述AD初期的线粒体的功能障碍的特征。
关键词: 阿尔茨海默病,生物标志物,线粒体,血小板,呼吸链,呼吸频率。
Current Alzheimer Research
Title:Mitochondrial Respiration in the Platelets of Patients with Alzheimer’s Disease
Volume: 13 Issue: 8
Author(s): Zdeněk Fišar, Jana Hroudová, Hana Hansíková, Jana Spáčilová, Petra Lelková, László Wenchich, Roman Jirák and Martina Zvěřová, Jiří Zeman, Pavel Martásek, Jiří Raboch
Affiliation:
关键词: 阿尔茨海默病,生物标志物,线粒体,血小板,呼吸链,呼吸频率。
摘要: Mitochondrial dysfunctions significantly contribute to the pathogenesis of Alzheimer’s disease (AD). Here, we studied the relationship between AD and changes in the mitochondrial rates of respiration in blood platelets, respiratory chain complexes activity, and coenzyme Q10 plasma concentrations. In intact platelets obtained from AD patients, we observed a decrease in endogenous basal respiration rates, a decrease in the maximal capacity of the electron transport system (ETS), and higher respiratory rates after inhibiting complex I of the ETS. When normalized for citrate synthase activity, rotenone inhibited respiratory rates and complex I activity was significantly altered. In permeabilized platelets, mitochondrial respiration was completely rescued by the addition of complex I substrates. The changes in mitochondrial respiratory parameters were not associated with the progression of AD except for the capacity of the ETS in permeabilized platelets. In AD, complex I activity was increased, complex IV activity was decreased, and coenzyme Q10 plasma concentrations were decreased. Our data indicate that both insufficiency in substrates entering into the oxidative phosphorylation system and functional disturbances in the ETS complex are responsible for the decrease in respiration observed in intact platelets in AD patients. Analyses of complex IV activity, the respiratory rates of intact platelets, and the capacity of the ETS in permeabilized platelets may enable the characterization of mitochondrial dysfunctions in the initial stage of AD.
Export Options
About this article
Cite this article as:
Zdeněk Fišar, Jana Hroudová, Hana Hansíková, Jana Spáčilová, Petra Lelková, László Wenchich, Roman Jirák and Martina Zvěřová, Jiří Zeman, Pavel Martásek, Jiří Raboch , Mitochondrial Respiration in the Platelets of Patients with Alzheimer’s Disease, Current Alzheimer Research 2016; 13 (8) . https://dx.doi.org/10.2174/1567205013666160314150856
DOI https://dx.doi.org/10.2174/1567205013666160314150856 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening Molecular Targeted Approaches for Treatment of Pancreatic Cancer
Current Pharmaceutical Design Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
Anti-Cancer Agents in Medicinal Chemistry Vasoactive Intestinal Peptide in Neurodevelopmental Disorders:Therapeutic Potential
Current Pharmaceutical Design RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease
Current Molecular Medicine Multi-Target Directed Compounds with Antioxidant and/or Anti- Inflammatory Properties as Potent Agents for Alzheimer’s Disease
Medicinal Chemistry Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinsons Disease?
Current Genomics Pharmacology of Cell Adhesion Molecules of the Nervous System
Current Neuropharmacology An Overview of Published Papers and Important Developments in the Past Three Years
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhibition of Early Biochemical Defects in Prodromal Huntington’s disease by Simultaneous Activation of Nrf2 and Elevation of Multiple Micronutrients
Current Aging Science Aging and Inflammation: Etiological Culprits of Cancer
Current Aging Science Malaria and artemisinin derivatives: an updated review
Mini-Reviews in Medicinal Chemistry Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein
Current Cancer Therapy Reviews Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases
Current Pharmaceutical Design Turning REST/NRSF Dysfunction in Huntingtons Disease into a Pharmaceutical Target
Current Pharmaceutical Design Biochemistry and Neurobiology of Prosaposin: A Potential Therapeutic Neuro-Effector
Central Nervous System Agents in Medicinal Chemistry Common Cellular and Molecular Mechanisms Underlying Alzheimer’s Disease and Type 2 Diabetes: A Knowledge-Driven Approach
CNS & Neurological Disorders - Drug Targets Recent Development of Peptide Drugs and Advance on Theory and Methodology of Peptide Inhibitor Design
Medicinal Chemistry Complement and Microglia in the Neuropathogenesis of HIV Infection: Pro- and Anti-Inflammatory Aspects
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Medicinal and Beneficial Health Applications of Tinospora cordifolia (Guduchi): A Miraculous Herb Countering Various Diseases/Disorders and its Immunomodulatory Effects
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)